Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
Titel:
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
Auteur:
Diaz Jr, Luis A Shiu, Kai-Keen Kim, Tae-Won Jensen, Benny Vittrup Jensen, Lars Henrik Punt, Cornelis Smith, Denis Garcia-Carbonero, Rocio Benavides, Manuel Gibbs, Peter de la Fourchardiere, Christelle Rivera, Fernando Elez, Elena Le, Dung T Yoshino, Takayuki Zhong, Wen Yan Fogelman, David Marinello, Patricia Andre, Thierry